Structure Therapeutics (GPCR) News Today → [Webinar] A Deep Dive into Options Volatility: Skew & Relative Value (From OIC) (Ad) Free GPCR Stock Alerts $37.43 -1.22 (-3.16%) (As of 12:26 PM ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineBuy Rating for Structure Therapeutics: Promising Pipeline and Financial Stability Ahead of Key Clinical Data Releasemarkets.businessinsider.com - May 10 at 6:25 AMGPCR Stock Earnings: Structure Therapeutics Beats EPS for Q1 2024investorplace.com - May 10 at 12:09 AMStructure Therapeutics Reports First Quarter 2024 Financial Results and Recent Highlightsfinance.yahoo.com - May 9 at 8:19 PME Fund Management Co. Ltd. Acquires Shares of 28,589 Structure Therapeutics Inc. (NASDAQ:GPCR)marketbeat.com - May 9 at 5:41 PMAmgen, newer rivals could threaten Novo Nordisk and Eli Lilly's weight loss drug dominancecnbc.com - May 7 at 11:33 AMStructure Therapeutics' (GPCR) "Overweight" Rating Reiterated at Cantor Fitzgeraldamericanbankingnews.com - May 7 at 5:42 AMStructure Therapeutics Inc. (NASDAQ:GPCR) Given Average Rating of "Buy" by Analystsamericanbankingnews.com - May 4 at 5:38 AMStructure Therapeutics (NASDAQ:GPCR) Given Overweight Rating at Cantor Fitzgeraldmarketbeat.com - May 3 at 8:49 PMShort Interest in Structure Therapeutics Inc. (NASDAQ:GPCR) Grows By 9.9%americanbankingnews.com - May 2 at 1:58 AMHere's what to expect from Corcept Therapeutics's earningsmarkets.businessinsider.com - April 30 at 11:16 AMStructure Therapeutics Inc. (NASDAQ:GPCR) Short Interest Up 9.9% in Aprilmarketbeat.com - April 30 at 6:42 AMStructure Therapeutics (NASDAQ:GPCR) Trading Up 8%marketbeat.com - April 25 at 8:24 PM3 Speculative Weight Loss Drug Stocks to Bet On for Big Gainsinvestorplace.com - April 24 at 6:33 AMAllspring Global Investments Holdings LLC Acquires Shares of 48,085 Structure Therapeutics Inc. (NASDAQ:GPCR)marketbeat.com - April 22 at 4:49 AMStructure Therapeutics Inc. (NASDAQ:GPCR) Shares Purchased by Federated Hermes Inc.marketbeat.com - April 19 at 8:27 AMBig pharma is looking to fatten profits with buyouts of weight-loss drug companies. Here are 4 candidates.msn.com - April 18 at 1:03 PMStructure Therapeutics' (GPCR) "Overweight" Rating Reaffirmed at Cantor Fitzgeraldmarketbeat.com - April 18 at 10:28 AMAnalysts Expect This 'Strong Buy' Weight-Loss Stock to Doubletheglobeandmail.com - April 18 at 8:02 AMStructure Therapeutics Inc. (GPCR)finance.yahoo.com - April 16 at 3:32 PMStructure Therapeutics Inc. (NASDAQ:GPCR) Short Interest Updatemarketbeat.com - April 14 at 11:14 PMCantor Fitzgerald Comments on Structure Therapeutics Inc.'s FY2024 Earnings (NASDAQ:GPCR)marketbeat.com - April 12 at 6:40 AMBuy Rating Affirmed for Structure Therapeutics on Upcoming GSBR-1290 Phase 2a Data Optimismmarkets.businessinsider.com - April 11 at 9:46 AMBuy Rating for Structure Therapeutics on Strong Obesity Drug Prospects and Strategic Partnershipsmarkets.businessinsider.com - April 10 at 2:11 PMCantor starts Structure at overweight, sees positive data for GLP-1 drugmsn.com - April 9 at 2:56 PMStructure Therapeutics (NASDAQ:GPCR) Stock Price Down 5.5%marketbeat.com - April 9 at 2:46 PMCantor Fitzgerald Initiates Coverage on Structure Therapeutics (NASDAQ:GPCR)marketbeat.com - April 9 at 8:24 AMStructure Therapeutics Inc. (NASDAQ:GPCR) Receives Consensus Recommendation of "Buy" from Brokeragesmarketbeat.com - April 9 at 8:12 AMLifesci Capital Weighs in on Structure Therapeutics Inc.'s Q1 2024 Earnings (NASDAQ:GPCR)marketbeat.com - April 3 at 6:00 AM7 Small-Cap Stocks that Wall Street Loves for Good Reasoninvestorplace.com - March 30 at 9:37 AMStructure Therapeutics (NASDAQ:GPCR) Stock Price Down 3.4%marketbeat.com - March 27 at 1:42 PMStructure Therapeutics (NASDAQ:GPCR) Shares Gap Up to $38.63marketbeat.com - March 21 at 3:14 PMFY2024 EPS Estimates for Structure Therapeutics Inc. Decreased by Leerink Partnrs (NASDAQ:GPCR)marketbeat.com - March 21 at 8:06 AMStructure Therapeutics (NASDAQ:GPCR) Trading Up 5%marketbeat.com - March 20 at 3:13 PMQ1 2024 Earnings Forecast for Structure Therapeutics Inc. (NASDAQ:GPCR) Issued By Leerink Partnrsmarketbeat.com - March 20 at 5:45 AMGPCR Dec 2024 50.000 callfinance.yahoo.com - March 20 at 5:30 AMWellington Management Group LLP Purchases 657,310 Shares of Structure Therapeutics Inc. (NASDAQ:GPCR)marketbeat.com - March 20 at 4:39 AMGPCR Sep 2024 30.000 putfinance.yahoo.com - March 17 at 5:00 PMGPCR May 2024 30.000 putfinance.yahoo.com - March 16 at 5:49 PMGPCR Apr 2024 30.000 putfinance.yahoo.com - March 16 at 5:49 PMGPCR Stock Earnings: Structure Therapeutics Beats EPS for Q4 2023msn.com - March 15 at 11:16 AMStructure Therapeutics (NASDAQ:GPCR) Trading Up 2.4%marketbeat.com - March 14 at 1:23 PMFormer CFO sues Peninsula drug company, alleges domestic violence incident led to her firingbizjournals.com - March 13 at 2:06 PMWe Think Structure Therapeutics (NASDAQ:GPCR) Can Afford To Drive Business Growthfinance.yahoo.com - March 10 at 1:47 PMGPCR Mar 2024 40.000 putfinance.yahoo.com - March 9 at 7:10 PMStructure Therapeutics to Present at Leerink Partners Global Biopharma Conferenceglobenewswire.com - March 8 at 4:05 PMStructure Therapeutics (NASDAQ:GPCR) Shares Up 8.3%marketbeat.com - March 8 at 12:43 PMStructure Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Highlightsglobenewswire.com - March 8 at 8:30 AMBuy Rating Affirmed for Structure Therapeutics Amidst Competitive Landscape and Promising Drug Prospectsmarkets.businessinsider.com - March 8 at 2:14 AMStructure Therapeutics Inc. (NASDAQ:GPCR) Short Interest Up 7.3% in Februarymarketbeat.com - March 5 at 3:17 PMStructure Therapeutics Inc. (NASDAQ:GPCR) Shares Purchased by Adage Capital Partners GP L.L.C.marketbeat.com - March 4 at 10:45 AM Get Structure Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for GPCR and its competitors with MarketBeat's FREE daily newsletter. Email Address [Webinar] A Deep Dive into Options Volatility: Skew & Relative Value (Ad)Join us for an exploration of essential volatility concepts in our "Volatility Fundamentals II: Skew & Relative Value" session. OIC® instructor Ken Keating will guide you through important topics that options investors should understand. Click here to register now (5/15 Webinar) GPCR Media Mentions By Week GPCR Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. GPCR News Sentiment▼0.400.45▲Average Medical News Sentiment GPCR News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. GPCR Articles This Week▼92▲GPCR Articles Average Week Get Structure Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for GPCR and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Evotec News Agios Pharmaceuticals News Amneal Pharmaceuticals News Galapagos News Syndax Pharmaceuticals News Catalyst Pharmaceuticals News Schrödinger News Harmony Biosciences News Avidity Biosciences News NewAmsterdam Pharma News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:GPCR) was last updated on 5/10/2024 by MarketBeat.com Staff From Our PartnersThe ONE AI Stock to own now. (It’s not Nvidia.)Weiss Ratings[Webinar] A Deep Dive into Options Volatility: Skew & Relative ValueOICConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThis 1 Biotech Stock has been shocking the marketsHuge AlertsTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaHe Is Giving Away BitcoinCrypto Swap ProfitsGold Set to EXPLODE!Gold Safe ExchangeCharles Payne Demystifies OptionsUnstoppable Prosperity Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Structure Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
